Molecular Biology Enzymes and Kits & Reagents Market - Increased Research Activities in the Pharmaceutical & Biotechnology Sector - Research and Markets

DUBLIN, October 3, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Molecular Biology Enzymes and Kits & Reagents Market - Trends & Global Forecasts to 2021" report to their offering.

The molecular biology enzymes and kits & reagents market is projected to reach USD 12.69 billion by 2021 from USD 5.77 billion in 2016, growing at a CAGR of 17.1% during the forecast period of 2016 to 2021.

The growth of the overall molecular biology enzymes and kits & reagents market include technological advancements in the life science industry, increased research activities in the pharmaceutical and biotechnology sector, rising incidences of infectious diseases and genetic disorders, and successful completion of human genome project.

The kits & reagents segment is expected to account for the largest share of the molecular biology enzymes and kits & reagents market, by product, in 2016. Increasing utilization of reagents in the research activities and growing use of kits in the molecular diagnostic assays attribute to the largest share of kits & reagents segment.

North America is expected to account for the largest share in the molecular biology enzymes and kits & reagents market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American region can be attributed to increasing research funding in applied markets; rising number of pharmaceutical & biotechnology companies; increasing prevalence of conditions involving molecular diagnostics, backed by reimbursement in the U.S.; and investments into research projects in Canada.

Asia-Pacific is expected to witness the highest growth rate in the forecast period, mainly due to the increasing government interest in biomedical and biotechnology industries in China, presence of bio-clusters in China, outsourcing of clinical research activities in China, conferences & meetings in Japan. Growing pharmaceutical industry backed by government initiatives in India, development of bio-clusters in India, Korea-U.S. free trade agreement, and initiatives by non-profit organizations in Asia-Pacific.

Companies Mentioned:

• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• F. Hoffmann-La Roche Ltd
• Illumina, Inc.
• Merck KGAA
• New England Biolabs, Inc.
• Promega Corporation
• Qiagen N.V.
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc

Key Topics Covered:

1 Molecular Biology Kits Market: Introduction

2 Molecular Biology Kits Market: Research Methodology

3 Molecular Biology Kits Market: Executive Summary

4 Premium Insights

5 Molecular Biology Kits Market: Market Overview

6 Industry Insights

7 Global Molecular Biology Enzymes and Kits & Reagents Market, By Product

8 Global Molecular Biology Enzymes and Kits & Reagents Market, By Application

9 Molecular Biology Enzymes and Kits & Reagents Market, By End User

10 Molecular Biology Enzymes and Kits & Reagents Market, By Region

11 Competitive Landscape

12 Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/rxnj7h/molecular_biology

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets